Clinical and Testing Protocols for the Analysis of Epidermal Growth Factor Receptor Mutations in East Asian Patients with Non-small Cell Lung Cancer: A Combined Clinical-Molecular Pathological Approach-Reference-Cited by-同舟云学术

Clinical and Testing Protocols for the Analysis of Epidermal Growth Factor Receptor Mutations in East Asian Patients with Non-small Cell Lung Cancer: A Combined Clinical-Molecular Pathological Approach

Published:2011-10 Issue:10 Volume:6 Page:1663-1669
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Salto-Tellez Manuel,Tsao Ming-Sound,Shih Jin-Yuan,Thongprasert Sumitra,Lu Shun,Chang Gee-Chen,Au Joseph Siu-Kie,Chou Teh-Ying,Lee Jong-Seok,Shi Yuan-Kai,Radzi Ahmad,Kang Jin-Hyoung,Kim Sang-We,Tan Soo-Yong,Yang James Chih-Hsin

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. First-line gefitinib in patients with advanced non-small cell lung cancer harboring somatic EGFR mutations;Sequist;J Clin Oncol,2008

2. A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations;Asahina;Br J Cancer,2006

3. Gefitinib for non-small cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp;Sutani;Br J Cancer,2006

4. Gefinitib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

5. Trends in cancer mortality in the elderly in Japan, 1970–2007

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular testing in lung cancer;Diagnostic Molecular Pathology;2024

2. Organoid drug screening report for a non-small cell lung cancer patient with EGFR gene mutation negativity: A case report and review of the literature;Frontiers in Oncology;2023-02-16

3. Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015–2017): A multicentre prospective study;The Lancet Regional Health - Western Pacific;2022-06

4. Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis;Molecular Diagnosis & Therapy;2021-11-23

5. Large Cell Neuroendocrine Carcinoma Transformation as a Mechanism of Acquired Resistance to Osimertinib in Non-small Cell Lung Cancer: Case Report and Literature Review;Clinical Lung Cancer;2021-08